Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.-论文-万方医学网

作者： Manh-Cuong,Vo ^[1] ; Thanh-Nhan,Nguyen-Pham ^[1] ; Hyun-Ju,Lee ^[2] ; Thangaraj,Jaya Lakshmi ^[1] ; Seoyun,Yang ^[2] ; Sung-Hoon,Jung ^[1] ; Hyeoung-Joon,Kim ^[2] ; Je-Jung,Lee ^[1]

作者单位： Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, Republic of Korea. ^[1] Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, Republic of Korea. ^[2]

主题词动物(Animals);抗原, 肿瘤(Antigens, Neoplasm);癌症疫苗(Cancer Vaccines);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);结肠肿瘤(Colonic Neoplasms);综合疗法(Combined Modality Therapy);细胞因子类(Cytokines);树突细胞(Dendritic Cells);疾病模型, 动物(Disease Models, Animal);女(雌)性(Female);基因表达(Gene Expression);免疫(Immunity);免疫疗法(Immunotherapy);杀伤细胞, 天然(Killer Cells, Natural);小鼠(Mice);T淋巴细胞, 细胞毒性(T-Lymphocytes, Cytotoxic);T淋巴细胞, 调节性(T-Lymphocytes, Regulatory);沙立度胺(Thalidomide);接种(Vaccination)

DOI 10.18632/oncotarget.15917

PMID 28460478

发布时间 2018-12-02

检索历史清除

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.

Oncotarget

相似文献

Oncotarget

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.

Oncotarget

相似文献

Oncotarget

相关期刊

检索历史清除